|
Lev Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
Market: Healthcare and Medical
Published Date: 22/04/2008
Market Research Report Title: Lev Pharmaceuticals Inc - Premium Company Profile
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 34
|
Enquire about Report |
Summary: Introduction
Lev Pharmaceuticals is a development stage biopharmaceutical company engaged in developing and commercializing therapeutics based on C1-esterase inhibitor (C1-INH) for the treatment of inflammatory diseases. Cinryze, the company’s lead drug candidate, is being developed for acute and prophylactic treatment of hereditary angioedema (HAE).
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies Highlights
Lev Pharmaceuticals in-licensed C1-INH from Sanquin in 2004. C1-INH is a human plasma protein that mediates inflammation and coagulation. Besides the current pipeline candidates, Lev Pharmaceuticals is also studying the use of C1-INH in the treatment of other inflammation-linked diseases such as gram-negative septicemia, inflammatory bowel disease, Alzheimer′s disease and stroke.The company did not record revenues during the period 2002-2006 because the company currently does market any products, and has no other source of revenues. Lev Pharmaceuticals forecasts to derive 100% of its revenues from the sales of Cinryze. The total revenues will grow from $43 million in 2008 to $143 million in 2010.Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
